SCHEMBL26327648

SCHEMBL26327648

CCCOC(=O)C(C(=O)OCCC)N(C1CCC1)C1CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 3/20 0.37
FDPS P14324 1/20 0.35
PPM1B O75688 1/20 0.35
PTPN1 P18031 1/20 0.35
PPP1CC P36873 1/20 0.35
ADH1C P00326 2/20 0.34
TSHR P16473 3/20 0.33
CYP3A4 P08684 2/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26328040 0.98 ADH1A (0.38) ADH1AFDPSPPM1BPTPN1PPP1CC
SCHEMBL26327646 0.96 PPM1B (0.37) ADH1APPM1BPTPN1PPP1CCTSHR
SCHEMBL25440013 0.74 TSHR (0.38) ADH1AFDPSADH1CTSHRS1PR1
SCHEMBL26327769 0.74 CHRM2 (0.44) TSHRCYP3A4CHRM2HTR1AADRA2A
SCHEMBL6062973 0.72 TSHR (0.44) PPM1BPTPN1PPP1CCTSHRCYP3A4
SCHEMBL20564174 0.72 TSHR (0.39) ADH1AFDPSADH1CTSHRS1PR1
SCHEMBL26327751 0.71 CHRM2 (0.43) TSHRCYP3A4CHRM2HTR1AADRA2A
SCHEMBL26327651 0.70 LMNA (0.44) TSHRCYP3A4CHRM2HTR1AADRA2A
SCHEMBL1837078 0.70 ADH1A (0.40) ADH1AADH1CLMNAMEN1ALDH1A1
SCHEMBL20564725 0.69 TSHR (0.36) FDPSTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 ADH1A 1100/4885FDPS 2828/4885PPM1B 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.